Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis

Claudia C. Dobler, Kelvin Cheung, John Nguyen, Andrew Martin

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Abstract

There is uncertainty regarding whether patients with cancer should be screened for latent tuberculosis infection (LTBI). We performed a systematic review and meta-analysis to estimate the relative incidence of tuberculosis (TB) in cancer.We searched MEDLINE and Embase for studies published before December 21, 2016. We included studies that evaluated the incidence of TB in patients with solid cancers and haematological malignancies relative to a reference group (study control or general population). A pooled estimate of the incidence rate ratio (IRR) was obtained using standard meta-analysis methods.The search strategy identified 13 unique studies including 921 464 patients with cancer. The IRR of TB for adult patients with cancer was 2.61 (95% CI 2.12-3.22; I2=91%). In haematological cancers, the IRR was 3.53 (95% CI 1.63-7.64; I2=96%); and in solid cancers in adults, it was 2.25 (95% CI 1.96-2.58; I2=91%). The highest IRR was found in children with haematological malignancies or solid cancers (IRR 16.82, 95% CI 8.81-32.12; I2=79%).Considering the limited duration of maximum immunosuppression in cancer and reduced cumulative lifetime risk of TB because of reduced life expectancy, children, but not adults, appear to be at a sufficient level of risk to warrant systematic screening for LTBI.

Original languageEnglish
JournalThe European respiratory journal
Volume50
Issue number2
DOIs
Publication statusPublished - 1 Aug 2017
Externally publishedYes

Fingerprint

Hematologic Neoplasms
Tuberculosis
Neoplasms
Incidence
Latent Tuberculosis
Meta-Analysis
Life Expectancy
MEDLINE
Immunosuppression
Uncertainty
Cohort Studies
Control Groups

Cite this

@article{c989211de4034c8c80af5324230ad3d0,
title = "Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis",
abstract = "There is uncertainty regarding whether patients with cancer should be screened for latent tuberculosis infection (LTBI). We performed a systematic review and meta-analysis to estimate the relative incidence of tuberculosis (TB) in cancer.We searched MEDLINE and Embase for studies published before December 21, 2016. We included studies that evaluated the incidence of TB in patients with solid cancers and haematological malignancies relative to a reference group (study control or general population). A pooled estimate of the incidence rate ratio (IRR) was obtained using standard meta-analysis methods.The search strategy identified 13 unique studies including 921 464 patients with cancer. The IRR of TB for adult patients with cancer was 2.61 (95{\%} CI 2.12-3.22; I2=91{\%}). In haematological cancers, the IRR was 3.53 (95{\%} CI 1.63-7.64; I2=96{\%}); and in solid cancers in adults, it was 2.25 (95{\%} CI 1.96-2.58; I2=91{\%}). The highest IRR was found in children with haematological malignancies or solid cancers (IRR 16.82, 95{\%} CI 8.81-32.12; I2=79{\%}).Considering the limited duration of maximum immunosuppression in cancer and reduced cumulative lifetime risk of TB because of reduced life expectancy, children, but not adults, appear to be at a sufficient level of risk to warrant systematic screening for LTBI.",
author = "Dobler, {Claudia C.} and Kelvin Cheung and John Nguyen and Andrew Martin",
year = "2017",
month = "8",
day = "1",
doi = "10.1183/13993003.00157-2017",
language = "English",
volume = "50",
journal = "European Journal of Respiratory Diseases",
issn = "0903-1936",
publisher = "EUROPEAN RESPIRATORY SOC JOURNALS LTD",
number = "2",

}

Risk of tuberculosis in patients with solid cancers and haematological malignancies : a systematic review and meta-analysis. / Dobler, Claudia C.; Cheung, Kelvin; Nguyen, John; Martin, Andrew.

In: The European respiratory journal, Vol. 50, No. 2, 01.08.2017.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Risk of tuberculosis in patients with solid cancers and haematological malignancies

T2 - a systematic review and meta-analysis

AU - Dobler, Claudia C.

AU - Cheung, Kelvin

AU - Nguyen, John

AU - Martin, Andrew

PY - 2017/8/1

Y1 - 2017/8/1

N2 - There is uncertainty regarding whether patients with cancer should be screened for latent tuberculosis infection (LTBI). We performed a systematic review and meta-analysis to estimate the relative incidence of tuberculosis (TB) in cancer.We searched MEDLINE and Embase for studies published before December 21, 2016. We included studies that evaluated the incidence of TB in patients with solid cancers and haematological malignancies relative to a reference group (study control or general population). A pooled estimate of the incidence rate ratio (IRR) was obtained using standard meta-analysis methods.The search strategy identified 13 unique studies including 921 464 patients with cancer. The IRR of TB for adult patients with cancer was 2.61 (95% CI 2.12-3.22; I2=91%). In haematological cancers, the IRR was 3.53 (95% CI 1.63-7.64; I2=96%); and in solid cancers in adults, it was 2.25 (95% CI 1.96-2.58; I2=91%). The highest IRR was found in children with haematological malignancies or solid cancers (IRR 16.82, 95% CI 8.81-32.12; I2=79%).Considering the limited duration of maximum immunosuppression in cancer and reduced cumulative lifetime risk of TB because of reduced life expectancy, children, but not adults, appear to be at a sufficient level of risk to warrant systematic screening for LTBI.

AB - There is uncertainty regarding whether patients with cancer should be screened for latent tuberculosis infection (LTBI). We performed a systematic review and meta-analysis to estimate the relative incidence of tuberculosis (TB) in cancer.We searched MEDLINE and Embase for studies published before December 21, 2016. We included studies that evaluated the incidence of TB in patients with solid cancers and haematological malignancies relative to a reference group (study control or general population). A pooled estimate of the incidence rate ratio (IRR) was obtained using standard meta-analysis methods.The search strategy identified 13 unique studies including 921 464 patients with cancer. The IRR of TB for adult patients with cancer was 2.61 (95% CI 2.12-3.22; I2=91%). In haematological cancers, the IRR was 3.53 (95% CI 1.63-7.64; I2=96%); and in solid cancers in adults, it was 2.25 (95% CI 1.96-2.58; I2=91%). The highest IRR was found in children with haematological malignancies or solid cancers (IRR 16.82, 95% CI 8.81-32.12; I2=79%).Considering the limited duration of maximum immunosuppression in cancer and reduced cumulative lifetime risk of TB because of reduced life expectancy, children, but not adults, appear to be at a sufficient level of risk to warrant systematic screening for LTBI.

UR - http://www.scopus.com/inward/record.url?scp=85045913818&partnerID=8YFLogxK

U2 - 10.1183/13993003.00157-2017

DO - 10.1183/13993003.00157-2017

M3 - Article

VL - 50

JO - European Journal of Respiratory Diseases

JF - European Journal of Respiratory Diseases

SN - 0903-1936

IS - 2

ER -